Provention Bio, Inc.

Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Company's pipeline includes clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in autoimmune diseases, including type 1 diabetes, celiac disease and lupus. Visit www.ProventionBio.com for more information and follow us on Twitter: @ProventionBio.

Provention Bio, Inc.

https://proventionbio.com/

PDF Files

Connected by T1D

Web Links

Connected by T1D

Video Chat Representatives

Please note that exhibitors will ONLY be available during the times they have listed in their availability. Please hover over the video chat buttons below to view each representative's availability.

When you click the chat buttons below you can pick one of two ways to join the chat. You can use your computer (modern browsers such as the latest versions of Google Chrome, Microsoft Edge, and Firefox are supported) or you can also join with the eventScribe Live app on your mobile device (a great alternative if you have problems connecting with your computer.